Regulations
Laws, ordinances, decrees, orders, decisions, notes and guidelines governing pharmaceutical products and medical devices.
141 texts found
- Note aux établissements 04-2026 Note No. 04-2026 on the development of the guideline on the prerequisites for renewing the registration decision Full text
- Note aux établissements 46-2025 Note No. 46-2025 on the extension of consultation deadlines Full text
- Note aux établissements 21-2026 Note No. 21-2026 on the guidelines cited in this note Full text
- Note aux établissements 08-2026 Note No. 08-2026 on the development of the guideline on communication Full text
- Note aux établissements 06-2026 Note No. 06-2026 to pharmaceutical establishments on making available the receipt forms for pharmaceutical products and medical devices Full text
- Note aux établissements 07-2026 Note No. 07-2026 on the development of the guideline on the preparation and submission of registration applications Full text
- Note aux établissements 10-2026 Note No. 10-2026 to pharmaceutical establishments on the Algerian Guide to Good Pharmacovigilance Practices Full text
- Note aux établissements 11-2026 Note No. 11-2026 on pharmaceutical establishments manufacturing and operating medical devices Full text
- Note aux établissements 12-2026 Note No. 12-2026 on the classification of observations arising from good practice inspections Full text
- Note aux établissements 09-2026 Note No. 09-2026 to pharmaceutical establishments on the batch recall and withdrawal guide Full text
- Note aux établissements 13-2026 Note No. 13-2026 on heat-sensitive pharmaceutical products Full text
- Note aux établissements 17-2026 Note No. 17-2026 on good review practices Full text
- Note aux établissements 16-2026 Note No. 16-2026 on regulatory reliance and recognition practices in the field of inspection Full text
- Note aux établissements 14-2026 Note No. 14-2026 on defining the roles and responsibilities of the entities involved in the pharmaceutical product registration procedure within the ANPP Full text
- Note aux établissements 18-2026 Note No. 18-2026 on the procedures for using the recognition pathway for laboratory testing of pharmaceutical products for human use Full text